Advances in BTK Inhibitor Therapy for B-Cell Lymphomas: Expert Discussion and Resources to Elevate Patient Care

This educational program aims to enhance the knowledge, competence, and confidence of healthcare professionals in understanding clinical data and recent advances on BTK inhibitors in the treatment of B-cell lymphomas to improve patient care. It targets hematology and oncology nurses as well as other healthcare professionals who care for patients with B-cell lymphomas.

Share

Program Content

Events

  • Live Event Advances in BTK Inhibitor Therapy for B-Cell Lymphomas: Expert Discussion and Resources to Elevate Patient Care
    Advances in BTK Inhibitor Therapy for B-Cell Lymphomas: Expert Discussion and Resources to Elevate Patient Care
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

BTKi Therapy for B-Cell Lymphomas
Advances in BTK Inhibitor Therapy for B-Cell Lymphomas: Expert Discussion and Resources to Elevate Patient Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 06, 2024

Expires: November 05, 2025

Faculty

cover img faculity

Emily Patterson, AGACNP-BC

Massachusetts General Hospital
Lymphoma Clinic
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC.

Supporters

Supported by an educational grant from BeiGene.

BeiGene

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner